Moderna Inc. (MRNA) Fundamentals

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
SHARE INFORMATION
Market CapUS$ 52.528.121.815
Shares Outstanding397.759.517
Float296.654.573
Percent Float74,58%
Short Interest0,00
Short Percent Float0,0%
Short Interest Ratio0,00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0,00
Latest Fiscal RevenueUS$ 18.471.000.000
Latest Fiscal EPSUS$ 28,29
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)US$ 0,00
Dividend (5 Years)US$ 0,00
Ex Dividend Date-
Dividend RateUS$ 0,00
Dividend Yield0,0%
Payment Cash-
HOLDERS
Institutions2.343
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months41.880.170
Institutional Holdings Percent127,7%
Institutional Sold Previous 3 Months33.738.434
Insider Holdings Date2022-03-31
Insider Bought Previous 3 Months513.106
Insider Holdings Percent5,7
Insider Sold Previous 3 Months943.661
Insider Shares Owned22.893.270
TRADING INFO
52 Week HighUS$ 497,49
52 Week LowUS$ 119,01
52 Week High ChangeUS$ -19,56
21 Day Moving AverageUS$ 138,5919
21 Day Extended Moving AverageUS$ 140,1335
50 Day Moving AverageUS$ 153,9112
50 Day Extended Moving AverageUS$ 149,9515
200 Day Moving AverageUS$ 248,7309
200 Day Extended Moving AverageUS$ 198,4717
10 Day Average Volume5.974.823
20 Day Average Volume6.765.956
30 Day Average Volume6.201.281
50 Day Average Volume6.756.419
Alpha0.067585
Beta1.6947
Standard Deviation0.302791
R20.085846
7 Day Price ChangeUS$ -10,22
7 Day Percent Change-7,18%
21 Day Price ChangeUS$ -14,48
21 Day Percent Change-9,88%
30 Day Price ChangeUS$ -8,28
30 Day Percent Change-5,9%
Month to Date Price ChangeUS$ -2,35
Month to Date Percent Change-1,75%
Quarter to Date Price ChangeUS$ -40,20
Quarter to Date Percent Change-23,34%
180 Day Price ChangeUS$ -141,33
180 Day Percent Change-51,7%
200 Day Price ChangeUS$ -104,93
200 Day Percent Change-44,28%
Year to Date Price ChangeUS$ -121,92
Year to Date Percent Change-48,0%

Moderna Inc. (MRNA) Key Ratios

PROFITABILITY
EBIT Margin72,0%
EBITDA Margin73,3%
Pre-Tax Profit Margin-257,0%
Profit Margin Count64,74%
Gross Margin84,8%
Profit Margin TOT64,74%
INCOME STATEMENTS
RevenueUS$ 22.600.000.000
Revenue Per ShareUS$ 56,8183
Revenue (3 Years)US$ 490,66
Revenue (5 Years)US$ 237,86
FINANCIAL STRENGTH
Price to Tangible Book3,20
Total Debt To Equity0,10
Int Coverage775,00
Current Ratio1,80
Leverage Ratio1,90
Quick Ratio1,50
Long Term Debt To Capital0,04
VALUATION MEASURES
PE Ratio4,00
Enterprise ValueUS$ 45.571.664.729
Price to Sales2,3243
Price to Free Cash4,20
PE High Last 5 Years0,00
Price To Book3,20
Price To Cash Flow4,40
PE Low Last 5 Years0,00
Price to Tangible Book3,20
MANAGEMENT EFFECTIVENESS
Receivables Turnover9,50
Invoice Turnover2,90
Assets Turnover1,30
Return Assets73,94
Return on Equity141,44
Return on Capital131,22

Moderna Inc. (MRNA) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorErnst & Young LLP
CEOStephane Bancel
Emplyoees2700
Last AuditUQ
CIK0001682852
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address200 Technology Square
Cambridge, MA 2139
Websitehttps://www.modernatx.com
Facsimile+1 617 583-1998
Telephone+1 617 714-6500
EmailLavina.Talukdar@modernatx.com
Seu Histórico Recente
NASDAQ
MRNA
Moderna
Registre-se agora para acompanhar essas ações ao vivo no Monitor ADVFN.

O Monitor permite ver até 110 de suas ações favoritas de uma vez só e é completamente grátis para você usar.

Cotações da NYSE e AMEX têm defasagem de no mínimo 20 minutos.
Quaisquer outras cotações têm defasagem de no mínimo 15 minutos quando não especificado.
Em caso de dúvidas por favor entre em contato com o suporte: suporte@advfn.com.br ou (11) 4950 5808.

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

P: V:br D:20220526 04:32:09